Day-to-day discrepancy in Bravo pH monitoring is related to the degree of deterioration of the lower esophageal sphincter and severity of reflux disease

BACKGROUND: The Bravo capsule allows monitoring of esophageal acid exposure over a two-day period. Experience has shown that 24–32% of patients will have abnormal esophageal acid exposure detected on only one of the 2 days monitored. This variation has been explained by the effect of endoscopy and s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayazi, Shahin, Hagen, Jeffrey A., Zehetner, Joerg, Banki, Farzaneh, Augustin, Florian, Ayazi, Ali, DeMeester, Steven R., Oh, Daniel S., Sohn, Helen J., Lipham, John C., DeMeester, Tom R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3116124/
https://www.ncbi.nlm.nih.gov/pubmed/21359906
http://dx.doi.org/10.1007/s00464-010-1529-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3116124/
https://www.ncbi.nlm.nih.gov/pubmed/21359906
http://dx.doi.org/10.1007/s00464-010-1529-5

Ejemplares similares